Abstract
Type 1 diabetes mellitus (T1DM) affects approximately 0.4–0.5% of the population. A 70% increase in prevalent cases of T1DM in those aged under 15 years in Europe
between 2005 and 2020 is predicted.1 T1DM continues to be associated with substantial mortality, with an estimated current period life expectancy differential of 11–13 years.2 The main chronic complications include cardiovascular disease
(CVD), nephropathy, retinopathy and neuropathy. CVD risk continues to be increased 2–3-fold relative to the general population, and diabetic kidney disease remains a major determinant of early mortality in people with T1DM
between 2005 and 2020 is predicted.1 T1DM continues to be associated with substantial mortality, with an estimated current period life expectancy differential of 11–13 years.2 The main chronic complications include cardiovascular disease
(CVD), nephropathy, retinopathy and neuropathy. CVD risk continues to be increased 2–3-fold relative to the general population, and diabetic kidney disease remains a major determinant of early mortality in people with T1DM
Original language | English |
---|---|
Pages (from-to) | 796-796i |
Number of pages | 10 |
Journal | International Journal of Epidemiology |
Volume | 46 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Jun 2017 |
Externally published | Yes |
Keywords
- Scottish
- Diabetes Research
- Type 1